gsk2186877a
Vaccineexperimental
Clinical trial activity
8 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
7
Phase 3
6
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT00753272)
Timeline
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gsk2186877a
- gsk2321138a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01954251 | Phase 3 | Oct 1, 2013 | GlaxoSmithKline |
| NCT01439360 | Phase 3 | Oct 1, 2011 | GlaxoSmithKline |
| NCT01195779 | Phase 2 | Sep 1, 2010 | GlaxoSmithKline |
| NCT01096056 | Phase 1 | Apr 1, 2010 | GlaxoSmithKline |
| NCT00992784 | Phase 3 | Oct 1, 2009 | GlaxoSmithKline |
| NCT00938392 | Phase 3 | Jul 1, 2009 | GlaxoSmithKline |
| NCT00765076 | Phase 3 | Oct 1, 2008 | GlaxoSmithKline |
| NCT00753272 | Phase 3 | Sep 1, 2008 | GlaxoSmithKline |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 8 | 8 | 3 | 2008 |
1 organizations
Page 1 / 1